As we noted in our in-depth last week, the digital health space is still holding its breath for big pharma and big payers to dive in with serious M&A. At the opening session for Digital Medicine Connect in Boston, a part of EBD Group’s BioPharm America conference, speakers from around the digital health world weighed in on how that landscape is changing.
“When I think about M&A in the...
